IP Library Granted Patent US 8,399,523
Granted Patent B2
US 8,399,523 · App. 12/747,722 · Granted Mar 19, 2013

Quarternization of the additive amino alkylmethacrylate copolymer E for improving permeability and solubility of pharmaceuticals

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,399,523
App. No.
12/747,722
Granted
Mar 19, 2013
Kind
B2
Abstract

The present invention relates to a strategy for improving the permeability and solubility of pharmaceuticals, based on adding a chemically modified amino alkyl methacrylate copolymer E, wherein the chemical modification is the quaternization of a fraction of the existing amino alkyl groups.

Claims (17)

1. An aminoalkyl methacrylate copolymer E, comprising at least one quaternized aminoalkyl group and at least one non-quaternized aminoalkyl group, wherein the aminoalkyl methacrylate copolymer E has formula (I)

wherein m is the total number of butyl methacrylate groups,

n is the total number of aminoalkyl groups,

o is the total number of methyl methacrylate groups,

q is the total number of quaternized aminoalkyl groups, and

m, n, o and q are each at least 1; and

wherein the proportion of the quaternized aminoalkyl groups relative to the total number of the aminoalkyl groups is more than 10% and less than 100%.

2. A method of producing the aminoalkyl methacrylate copolymer E according to claim 1 , comprising

reacting a methyl iodide with at least one aminoalkyl group of an aminoalkyl methacrylate copolymer precursor.

3. The method according to claim 2 , wherein the reacting is carried out in the presence of methanol as a solvent.

4. A method for improving the permeability and solubility of a pharmaceutical composition, comprising

administering an aminoalkyl methacrylate copolymer E according to claim 1 with the pharmaceutical composition.

5. A pharmaceutical formulation comprising at least one pharmaceutical compound and the aminoalkyl methacrylate copolymer E according to claim 1 .

6. The aminoalkyl methacrylate copolymer E according to claim 1 , wherein the proportion of the quaternized aminoalkyl groups relative to the total number of the aminoalkyl groups is more than 20% and less than 100%.

7. A pharmaceutical formulation comprising at least one pharmaceutical compound and an aminoalkyl methacrylate copolymer E according to claim 6 .

8. The aminoalkyl methacrylate copolymer E according to claim 1 , wherein the proportion of the quaternized aminoalkyl groups relative to the total number of the aminoalkyl groups is from 22 to 65%.

9. The aminoalkyl methacrylate copolymer E according to claim 1 , wherein the aminoalkyl methacrylate copolymer with the quaternized aminoalkyl groups has a greater permeability-promoting action in comparison to an aminoalkyl methacrylate copolymer precursor.

Assignments (3)
CHANGE OF NAME Recorded Feb 11, 2020
From: EVONIK ROEHM GMBH
To: ROEHM GMBH
Reel/Frame 051893/0671 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2020
From: ROEHM GMBH
To: EVONIK DEGUSSA GMBH
Reel/Frame 051893/0727 →
CHANGE OF NAME Recorded Feb 11, 2020
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051894/0001 →